Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circulating Tumor Cells in Castration-Resistant Metastatic Prostate Cancer Undergoing Zoledronic Acid Therapy
2011-003154-12Phase 4Active
- Sponsor
- Privatärztliche urologische Partnerschaft
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of zoledronic acid in prostate cancer (PCa), sponsored by Privatärztliche urologische Partnerschaft. Primary endpoint: Proportion of patients with decreased CTCs at 12 weeks. Started Aug 2011; status: active.
02
Drugs
zoledronic acid
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2011-003154-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003154-12.